Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families-Reference-Cited by-同舟云学术

Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families

Published:2007-05-31 Issue:3 Volume:108 Page:399-408
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Arcand Suzanna L.,Maugard Christine M.,Ghadirian Parviz,Robidoux André,Perret Chantal,Zhang Phil,Fafard Eve,Mes-Masson Anne-Marie,Foulkes William D.,Provencher Diane,Narod Steven A.,Tonin Patricia N.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-007-9608-6.pdf

Reference42 articles.

1. Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63(5):1341–1351

2. Oros KK, Ghadirian P, Greenwood CM, Perret C, Shen Z, Paredes Y, Arcand SL, Mes-Masson AM, Narod SA, Foulkes WD et al (2004) Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int J Cancer 112(3):411–419

3. Oros KK, Ghadirian P, Maugard CM, Perret C, Paredes Y, Mes-Masson AM, Foulkes WD, Provencher D, Tonin PN (2006) Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. Clin Genet 70(4):320–329

4. Antoniou AC, Durocher F, Smith P, Simard J, Easton DF (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French–Canadian families. Breast Cancer Res 8(1):R3

5. Simard J, Dumont M, Moisan AM, Gaborieau V, Vezina H, Durocher F, Chiquette J, Plante M, Avard D, Bessette P et al (2007) Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multi-step testing approach in French–Canadian high-risk breast and ovarian cancer families. J Med Genet 44(2):107–121

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases;Frontiers in Oncology;2023-03-08

2. Germline TP53 pathogenic variants and breast cancer: A narrative review;Cancer Treatment Reviews;2023-03

3. Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene;Genes;2023-01-20

4. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene;Genome Medicine;2021-12

5. The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families;Cancers;2021-07-07